Advances in MRI-based bone quality scoring systems and their clinical applications.
10.7507/1002-1892.202410072
- Author:
Jianzhi WANG
1
;
Lei WANG
1
;
Yueming SONG
1
Author Information
1. Department of Orthopedics, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P. R. China.
- Publication Type:English Abstract
- Keywords:
MRI;
bone density;
bone quality scoring system;
osteoporosis
- MeSH:
Humans;
Magnetic Resonance Imaging/methods*;
Bone Density;
Osteoporosis/diagnosis*;
Absorptiometry, Photon;
Bone and Bones/diagnostic imaging*;
Lumbar Vertebrae/diagnostic imaging*;
Quality of Life;
Postoperative Complications
- From:
Chinese Journal of Reparative and Reconstructive Surgery
2025;39(3):370-374
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To summarize the advances in MRI-based bone quality scoring systems and their clinical applications.
METHODS:A comprehensive literature review was conducted on recent studies related to the MRI-based bone quality scoring system, focusing on measurement methods, influencing factors, and clinical significance.
RESULTS:Osteoporosis has a high incidence in China, significantly impacting patients' quality of life and the postoperative outcomes of related orthopedic surgeries. Early identification of osteoporosis holds important clinical significance. In recent years, both domestic and international research has enriched the MRI-based bone quality scoring systems, which includes vertebral bone quality scoring, endplate bone quality scoring, and pedicle bone quality scoring. Compared to the "gold standard" of bone density measurement, dual-energy X-ray absorptiometry, the bone quality scoring systems demonstrate good efficacy in identifying abnormal bone mass and predicting postoperative complications, while being less influenced by degenerative changes in the lumbar spine, indicating its important clinical application value.
CONCLUSION:The MRI-based bone quality scoring systems have good value in clinical applications. However, current studies are mostly retrospective cohort and case-control studies, which carry a risk of bias. The clinical application value needs further clarification through meta-analysis and large-scale prospective studies.
